Masitinib

5 trials LOncology Orphan designation

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

10 Countries

Phase III

Phase II

Phase III: 4 Phase II: 1

Oversight events:

14 temporary halts 5 corrective measures across 5 trials

View oversight register →

Indications tested

Amyotrophic lateral sclerosis 1

Sponsors using this IMP

All trials

5 total

A 24-week with possible extension, prospective, multicenter, randomized, double blind, placebo-controlled, 2-parallel group with a randomiza… Halted

2024-514538-19-00 Phase III 3 countries Ab Science
A 24-week, multicenter, randomized, double blind, placebo-controlled, dose-range finding phase II study to compare efficacy and safety of or… Halted

2024-515193-27-00 Phase II 1 country Ab Science
A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib… Halted

2024-516672-16-00 Phase III 4 countries Ab Science
A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 3 study to compare the efficacy and safety … Halted

2024-516671-33-00 Phase III 5 countries Ab Science
A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel groups, phase 3 Trial to compare the efficacy and safety … Suspended

2024-511244-12-01 Phase III 7 countries Ab Science

Showing 1–5 of 5 trials

← All drugs A–Z